Impedimed believes that strides are being made towards reaching profitability in the oncology arena.
The company is adamant there are no plans to leave the Australian Securities Exchange, nor are there intentions to seek listing on Nasdaq or any other foreign exchange.
Impedimed (ASX:IPD) is focused on both domestic and global expansion in the healthcare sector.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
